· PC
· PK
· PD
Presentation |
· 5mg in 5mL ampoule, aqueous solution Also as tablets |
Structure |
· Heterocyclic benzodiazepine · Imidazole moiety |
Tautomerism |
· In ampoule: pH 3.5, diaz ring open, water soluble (protonation of imidazole nitrogen) · In blood: pH 7.4 diaz ring closed, lipid soluble, can cross blood-brain barrier · Transformation at pH 4 |
Ionisation |
· pKa 6.5, weak base. 90% unionized at pH 7.4 |
Routes |
· IV, IM, SC, PO, IN, PR |
Dosing |
· IV induction: 0.3mg/kg · IV pre-induction adjuvant: 0.025mg/kg · PO pre-med: 0.5mg/kg |
Time course (short acting) |
· Onset IV 2 mins · Peak IV 10 mins · Duration IV 1-6 hours (prolonged if elderly, liver disease, acute illness) |
Absorption |
· Oral bioav 50% |
Distribution |
· Plasma protein binding 98% · VDSS 1.5L/kg · Highly lipid soluble · t1/2ke0 4 minutes |
Metabolism |
· Hepatic · Phase 1 (3A4) then phase 2 · Cl 5-10mL/kg/min · Active metabolites: α-OH-midaz (50% as active) and oxazepam (active) o These undergo glucuronidation · t1/2β 2 hours |
Excretion |
· <1% midazolam -> urine · Glucuronidated metabolites -> urine |
Mechanism of action |
· Positive allosteric modulator at BDZ site on GABA-A receptor, at A-G interface · ↑probability of active conformation · ↑Cl- conductance, prevention of depolarisation to action potential · (Not hyperpolarization, since RMP -70mV and Cl- Nernst potential -65mV) |
GABA-A subtypes |
· α1: sedation, amnesia, anticonvulsant · α2, α3: muscle relaxation, anxiolysis |
Drug interactions |
· Synergistic with propofol, volatile anaesthetics at GABA-A · Synergistic with opioids in causing respiratory depression · Antagonised by flumazenil (competitive antagonist) |
Specific use |
· Premedication for children · Sedation for procedures or in ICU · Adjuvant at induction · Induction agent if high cardiovascular risk (e.g. CABG with fentanyl) |
CNS effects |
Dose-dependent in this order: · Anxiolysis · Antegrade amnesia · Sedation · Anticonvulsant · Muscle relaxation · Hypnosis (here?) Also: · ↓MAC · ↓CMRO2 · ↓Side effects of ketamine · 10% risk paradoxical reaction in children; agitation, violence etc. |
Respiratory |
· ↓TV more than ↓RR; mild ↑PaCO2 o Synergistic depression with opioids o Can be dangerous if sleep-disordered breathing · ↓Airway reflexes |
Cardiovascular |
· ↓SNS output: -> mild ↓cardiac output, ↓SVR, ↓mAP |
Special |
· Paradoxical reaction 1 in 10 children; agitation, rage · Much slower offset if elderly, unwell, liver failure (? slower metabolite elimination) · Risk delirium in elderly, ? risk of prolonged cognitive impairment |
Feedback welcome at ketaminenightmares@gmail.com